Future Ear Radio Ep 132 - Lenire: The First FDA-Approved Bimodal Tinnitus Treatment

Описание к видео Future Ear Radio Ep 132 - Lenire: The First FDA-Approved Bimodal Tinnitus Treatment

Guests: Guests: Ross O'Neill Ph.D (Founding CEO) & Hubert Lim Ph.D (Chief Scientific Officer) of Neuromod

Dave is joined on the podcast this week by Ross & Hubert to discuss:

The backstory of how Ross & Hubert met and ultimately partnered together on Lenire

Hubert's research and papers he wrote about paired stimulation & Pavlovian conditioning, which included data that identified tongue stimulation combined with sound as a promising direction to pursue

An overview of what exactly tinnitus is and why Lenire presents such a novel approach to treating tinnitus

Other types of synchronous-stimuli approaches that have emerged in other healthcare verticals (i.e. mirror therapy for phantom limb pain)

The challenging process of gaining FDA approval and the clinical trials that were conducted throughout the process

Being featured as ⁠the cover story⁠ on Nature Communications

The initial roll-out of Lenire, the current state of the provider network, and the real-world data that's being collected and published

Комментарии

Информация по комментариям в разработке